Iridium‐Catalyzed Enantioselective Allylation of Alkynylboronates to Access Chiral 1,4‐Dienes
Abstract
ABSTRACT Skipped dienes, particularly 1,4‐dienes, play significant roles in pharmaceuticals and organic synthesis as they serve as key intermediates for the construction of complex structures and also bioactive molecules. However, the catalytic assembly of this motif with high stereoselectivity from readily available starting materials remains a substantial synthetic challenge. Herein, we reported a direct iridium‐catalyzed enantioselective allylation reaction with allylic electrophiles and alkynyl boronates, resulting in various 1,4‐dienes with excellent Z/E ratios and enantioselectivity. The reaction proceeds through a concerted mechanism that involves an allylation‐induced 1,2‐migration of the alkynyl boronate, followed by a syn ‐addition of the migrating group and Ir( π ‐allyl) complex across the alkynyl fragment to selectively deliver the more challenging Z‐alkenes. DFT calculations clarify the origins of the observed high chemo‐ and stereoselectivity. Furthermore, this method demonstrates a broad substrate scope, and the resulting enantiomerically enriched 1,4‐diene products can be readily derivatized.
Article Details
Authors (8)
Fengya He
Key Laboratory of Functional Molecular Solids (Ministry of Education), Anhui Key Laboratory of Molecular Based Materials, College of Chemistry and Materials Science Anhui Normal University Wuhu China
Ziyi Sun
Department of Chemistry, McGill University, 801 Sherbrooke Street. W, Montreal, Quebec H3A0B8, Canada
Xu Zhang
Zhen Long
Shanghai Frontiers Science Center of Molecule Intelligent Syntheses, School of Chemistry and Molecular Engineering, Wuhu Hospital Affiliated to East China Normal University East China Normal University Shanghai China
Quansheng Zhao
Key Laboratory of Functional Molecular Solids (Ministry of Education), Anhui Key Laboratory of Molecular Based Materials, College of Chemistry and Materials Science Anhui Normal University Wuhu China
Lianrui Hu
Shanghai Engineering Research Center of Molecular Therapeutics and New Drug Development, Shanghai Frontiers Science Center of Molecule Intelligent Syntheses, School of Chemistry and Molecular Engineering
Liang Fu
Hui Wang